Prognostic value of HMGB3 expression in patients with non-small cell lung cancer
Authors:
- 23 April 2013
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 34 (5) , 2599-2603
Abstract
HMGB3 overexpression has been reported in a variety of human cancers. However, the role of HMGB3 in human non-small cell lung cancer (NSCLC) remains unclear. In this study, the HMGB3 expression was examined at mRNA and protein levels by quantitative real-time reverse transcriptase–polymerase chain reaction (qRT-PCR), Western blotting, and immunohistochemistry in NSCLC tissues and adjacent non-cancerous tissues. Statistical analyses were applied to test the associations between HMGB3 expression, clinicopathologic factors, and prognosis. Western blotting and qRT-PCR showed that the expression levels of HMGB3 mRNA and protein were both significantly higher in NSCLC tissues than those in non-cancerous tissues. Immunohistochemistry analysis showed that HMGB3 expression was significantly correlated with tumor grade, tumor size, clinical stage, and lymph node metastases. The results of Kaplan–Meier analysis indicated that a high expression level of HMGB3 resulted in a significantly poor prognosis of NSCLC patients. Importantly, multivariate analysis showed that high HMGB3 expression was an independent prognostic factor for NSCLC patients. In sum, our data suggest that HMGB3 plays an important role in NSCLC progression, and that overexpression of HMGB3 in tumor tissues could be used as a potential prognostic marker for patients with NSCLC.Keywords
This publication has 12 references indexed in Scilit:
- High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinomaWorld Journal of Gastroenterology, 2012
- HMGB proteins: Interactions with DNA and chromatinBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- NUP98–HMGB3: a novel oncogenic fusionLeukemia, 2009
- Targeted therapies in the treatment of advanced/metastatic NSCLCEuropean Journal of Cancer, 2009
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem CellsCell Stem Cell, 2009
- Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiationProceedings of the National Academy of Sciences, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- HMGB proteins and gene expressionCurrent Opinion in Genetics & Development, 2003
- Hmg4,a New Member of theHmg1/2Gene FamilyGenomics, 1998
- Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical studyCancer, 1993